Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NY › NEW YORK › NYU LANGONE HOSPITALS

NYU LANGONE HOSPITALS

NPI: 1669578324 · NEW YORK, NY 10003 · Rehabilitation Hospital Unit · NPI assigned 09/16/2006

$32.22M
Total Medicaid Paid
360,576
Total Claims
260,029
Beneficiaries
182
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSMITH, WESLEY (VP REVENUE CYCLE)
Parent OrganizationNYU LANGONE HOSPITALS
NPI Enumeration Date09/16/2006

Related Entities

Other providers sharing the same authorized official: SMITH, WESLEY

ProviderCityStateTotal Paid
NYU LANGONE HOSPITALS BROOKLYN NY $303.18M
NYU LANGONE HOSPITALS NEW YORK NY $238.69M
NYU LANGONE HOSPITALS NEW YORK NY $117.59M
NYU LANGONE HOSPITALS MINEOLA NY $69.77M
NYU LANGONE HOSPITALS NEW YORK NY $3.50M
NYU LANGONE HOSPITALS BROOKLYN NY $453K
NYU LANGONE HOSPITALS BROOKLYN NY $99K
NYU LANGONE HOSPITALS BROOKLYN NY $9K
NYU HOSPITALS CENTER NEW YORK NY $55.44

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,817 $137K
2019 20,676 $1.68M
2020 53,888 $4.40M
2021 72,402 $5.84M
2022 72,870 $6.18M
2023 74,697 $7.76M
2024 63,226 $6.22M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
97530 Therapeutic activities, direct patient contact, each 15 minutes 31,412 11,739 $4.24M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 51,341 23,674 $4.19M
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 2,084 2,065 $3.36M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 18,131 15,694 $2.97M
C1889 Implantable/insertable device, not otherwise classified 1,861 1,840 $1.82M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 14,712 13,769 $1.57M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11,066 10,431 $1.30M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 8,653 8,370 $1.23M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 8,893 2,680 $1.06M
97161 8,781 8,630 $994K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 21,798 10,313 $720K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 10,857 6,440 $687K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4,936 4,736 $615K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3,229 2,215 $525K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 5,023 1,527 $520K
C1776 Joint device (implantable) 68 67 $436K
20610 851 738 $407K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 1,749 1,655 $376K
97165 3,357 3,314 $370K
97116 4,242 2,568 $339K
96415 839 770 $279K
72082 5,126 4,663 $272K
29888 89 89 $263K
29881 195 191 $232K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 1,039 1,032 $177K
76000 1,099 1,090 $147K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 977 969 $142K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 9,038 8,455 $129K
73562 5,173 4,196 $129K
73221 589 572 $120K
99215 Prolong outpt/office vis 615 590 $103K
73564 3,768 2,802 $101K
97162 805 800 $97K
J1745 Injection, infliximab, excludes biosimilar, 10 mg 57 38 $91K
77073 4,033 3,750 $90K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,852 1,128 $88K
20611 118 109 $85K
92609 792 257 $83K
97113 602 220 $79K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,070 1,050 $75K
73030 2,591 2,287 $73K
73502 2,641 2,313 $72K
73610 2,767 2,433 $70K
72141 331 324 $70K
29827 25 25 $66K
97535 Self-care/home management training, each 15 minutes 654 476 $64K
73630 3,115 2,608 $61K
73130 2,493 1,914 $50K
76882 1,002 927 $49K
92523 247 247 $48K
73110 1,986 1,624 $44K
73560 2,025 1,720 $43K
95911 235 234 $39K
99205 Prolong outpt/office vis 294 291 $39K
29705 133 117 $37K
73080 1,620 1,352 $36K
95886 771 766 $36K
72170 2,150 1,940 $34K
72110 1,185 1,093 $33K
96375 Therapeutic injection; each additional sequential IV push 1,092 949 $33K
97166 270 267 $32K
96116 195 192 $32K
72100 1,151 1,076 $31K
J7120 Ringers lactate infusion, up to 1000 cc 5,159 4,318 $31K
80053 Comprehensive metabolic panel 1,779 1,621 $29K
97542 229 220 $28K
J3490 Unclassified drugs 7,240 5,123 $28K
73590 1,285 1,103 $27K
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) 14 14 $24K
71046 Radiologic examination, chest; 2 views 754 716 $22K
29823 28 28 $21K
J2704 Injection, propofol, 10 mg 5,722 4,378 $19K
72083 280 267 $18K
86900 660 643 $17K
90834 Psychotherapy, 45 minutes with patient 191 80 $17K
C1769 Guide wire 123 121 $17K
J0585 Injection, onabotulinumtoxina, 1 unit 40 40 $15K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 666 654 $12K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 114 113 $12K
J7030 Infusion, normal saline solution , 1000 cc 4,679 2,751 $12K
73090 772 633 $12K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 1,998 1,889 $11K
J0690 Injection, cefazolin sodium, 500 mg 3,862 3,505 $11K
80048 Basic metabolic panel (calcium, ionized) 892 805 $11K
76881 201 169 $10K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 357 328 $10K
20550 13 12 $9K
64642 12 12 $9K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3,113 2,849 $9K
72050 250 233 $8K
86850 663 646 $8K
72040 261 243 $8K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 607 581 $8K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 40 36 $8K
96132 67 64 $7K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 599 583 $6K
86901 662 645 $5K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 991 969 $5K
76942 27 26 $5K
J2795 Injection, ropivacaine hydrochloride, 1 mg 1,891 1,516 $5K
73140 279 235 $5K
87070 952 915 $5K
J3010 Injection, fentanyl citrate, 0.1 mg 4,869 4,279 $5K
36415 Collection of venous blood by venipuncture 610 601 $5K
80076 294 264 $5K
86160 329 283 $4K
96136 65 65 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,837 3,498 $4K
96137 53 53 $4K
86140 1,684 1,497 $4K
A9585 Injection, gadobutrol, 0.1 ml 142 115 $3K
73700 43 40 $3K
L3808 Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment 14 13 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 254 221 $3K
73552 143 127 $3K
Q3014 Telehealth originating site facility fee 103 100 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,919 3,689 $3K
85652 1,996 1,789 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg 1,887 1,743 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg 4,289 4,240 $2K
84703 1,883 1,806 $2K
94060 18 17 $2K
J7050 Infusion, normal saline solution, 250 cc 522 477 $2K
94726 48 47 $2K
94729 48 47 $2K
72114 38 37 $2K
J1030 Injection, methylprednisolone acetate, 40 mg 164 163 $2K
73523 57 53 $2K
80061 Lipid panel 95 81 $2K
86225 275 231 $2K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 1,057 937 $1K
G0008 Administration of influenza virus vaccine 82 82 $1K
90686 65 65 $1K
J1170 Injection, hydromorphone, up to 4 mg 496 469 $1K
96121 26 26 $1K
73521 35 30 $1K
99283 Emergency department visit for the evaluation and management, moderate severity 14 14 $1K
72081 43 37 $995.54
87640 46 46 $898.22
88305 Level IV - Surgical pathology, gross and microscopic examination 14 14 $863.39
85027 331 303 $847.26
J3370 Injection, vancomycin hcl, 500 mg 129 121 $701.76
81003 525 458 $692.18
72070 25 25 $687.99
J0171 Injection, adrenalin, epinephrine, 0.1 mg 67 67 $668.55
84443 Thyroid stimulating hormone (TSH) 109 98 $616.79
85730 155 142 $616.62
73100 42 33 $613.10
77080 13 13 $558.86
85610 162 149 $519.80
83036 Hemoglobin; glycosylated (A1C) 153 143 $507.37
72202 15 12 $414.99
73000 13 12 $403.03
73070 17 14 $373.10
77072 12 12 $352.06
86431 88 78 $283.59
97810 32 12 $282.69
73010 13 13 $271.36
J2919 Injection, methylprednisolone sodium succinate, 5 mg 48 40 $252.87
97811 32 12 $240.57
99284 Emergency department visit for the evaluation and management, high severity 14 14 $205.31
84156 96 80 $201.65
86200 30 24 $195.44
87081 46 46 $181.24
71045 Radiologic examination, chest; single view 14 14 $174.83
82948 159 99 $78.68
J1580 Injection, garamycin, gentamicin, up to 80 mg 12 12 $75.60
J2003 Injection, lidocaine hydrochloride, 1 mg 51 50 $66.34
J2370 Injection, phenylephrine hcl, up to 1 ml 40 40 $63.13
86039 15 13 $60.92
J1200 Injection, diphenhydramine hcl, up to 50 mg 55 52 $54.41
S0028 Injection, famotidine, 20 mg 57 51 $43.61
81015 28 24 $31.96
84550 15 13 $22.60
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 405 324 $9.88
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 53 52 $2.44
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 25 25 $0.20
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 25 25 $0.20
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 257 250 $0.20
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 252 249 $0.20
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 12 12 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 12 12 $0.00